Search Orphan Drug Designations and Approvals
-
Generic Name: | Recombinant humanized, non-fucosylated IgG1 anti-Siglec-8 monoclonal antibody |
---|---|
Date Designated: | 10/30/2019 |
Orphan Designation: | Treatment of eosinophilic esophagitis |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 05/16/2024 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Allakos, Inc. 75 Shoreway Road Suite A San Carlos, California 94070 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-